DrugDashboards

Tramadol Hydrochloride

Tramadol Hydrochloride · TRAMADOL HYDROCHLORIDE 200 mg/1 · Tablet, Film Coated, Extended Release · Oral · Macleods Pharmaceuticals Limited

NDC 33342-0270-07 · 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.5$1.00$1.50Mar 2026Sep 2026$1.24
6 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$37.14
#90 count
$111.42

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2026 YTD · Q1)

$3,595
66 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

20Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 2 active manufacturers+20

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for tramadol hydrochloride (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market · 1 Class I/II recall(s) in 12 months

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application
ANDA209404
TE code
AB1
Approval date
Jan 31, 2025
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Tramadol Hydrochloride (Tablet, Film Coated, Extended Release)

LabelerStrengthFirst seenLast seen
Macleods Pharmaceuticals LimitedTRAMADOL HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedTRAMADOL HYDROCHLORIDE 200 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedTRAMADOL HYDROCHLORIDE 300 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPTRAMADOL HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Tramadol Hydrochloride — NDC 33342-0270-07," retrieved September 3, 2026, https://drugdashboards.com/drug/33342027007.

Free to cite with attribution — see how the data is put together.